Motor complications, levodopa metabolism and progression of Parkinson's disease

Cysteinyl-glycine reduction as marker for levodopa-induced oxidative stress in Parkinson's disease patients

(2011) Thomas Müller et al.   MOVEMENT DISORDERS

Environmental Neurotoxic Pesticide Increases Histone Acetylation to Promote Apoptosis in Dopaminergic Neuronal Cells: Relevance to Epigenetic Mechanisms of Neurodegeneration

(2010) C. Song et al.   MOLECULAR PHARMACOLOGY

Acute homocysteine rise after repeated levodopa application in patients with Parkinson’s disease

(2010) Thomas Müller et al.   PARKINSONISM & RELATED DISORDERS

Occupation and Risk of Parkinsonism

(2009) Caroline M. Tanner et al.   ARCHIVES OF NEUROLOGY

Dopaminergic treatment is associated with decreased body weight in patients with Parkinson’s disease and dyskinesias

(2009) C. G. Bachmann et al.   EUROPEAN JOURNAL OF NEUROLOGY

Mitochondria Are the Source of Hydrogen Peroxide for Dynamic Brain-Cell Signaling

(2009) L. Bao et al.   JOURNAL OF NEUROSCIENCE

Homocysteine levels after acute levodopa intake in patients with Parkinson's disease

(2009) Thomas Müller et al.   MOVEMENT DISORDERS

Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study

(2009) Maria C. Rodriguez-Oroz et al.   MOVEMENT DISORDERS

Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy

(2009) Davide Manca et al.   MOVEMENT DISORDERS

Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment

(2009) Marco Onofrj et al.   PARKINSONISM & RELATED DISORDERS

Glutathione and Parkinson's disease: Is this the elephant in the room?

(2008) Gail D. Zeevalk et al.   BIOMEDICINE & PHARMACOTHERAPY

Role of homocysteine in the treatment of Parkinson's disease

(2008) Thomas Müller   Expert Review of Neurotherapeutics

Molecular mechanisms underlying levodopa-induced dyskinesia

(2008) Paolo Calabresi et al.   MOVEMENT DISORDERS

Neuropathy as a potential complication of levodopa use in Parkinson's disease

(2008) Cory Toth et al.   MOVEMENT DISORDERS

Molecular mechanisms of L-DOPA-induced dyskinesia

(2008) Peter Jenner   NATURE REVIEWS NEUROSCIENCE

Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus

(2007) Chang-E. Zhang et al.   NEUROBIOLOGY OF AGING

Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation

(2007) Masato Asanuma et al.   NEUROSCIENCE RESEARCH